Document Preview Unavailable
The immunomodulatory properties of the HDAC6 inhibitor ACY241 supports robust anti-tumor response in NSCLC when coupled with the chemotherapy drug Oxaliplatin
Bag, Arup; Schultz, Andrew; Bhimani, Saloni; Dominguez, William; Cen, Ling; et al. bioRxiv, Oct 2, 2021.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library